ArticlePharmaceutics2022

Nanomedicines Bearing an Alkylating Cytostatic Drug from the Group of 1,3,5-Triazine Derivatives: Development and Characterization.

Ekaterina Sinitsyna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.